A State-of-the-Art Review Highlighting Medical Overuse in Dermatology, 2017-2018: A Systematic Review

Ashley B. Pournamdari, Elizabeth Tkachenko, John Barbieri, Adewole S. Adamson, Arash Mostaghimi

Research output: Contribution to journalReview article

Abstract

Importance: Emerging efforts to recognize and combat medical overuse are important solutions to mitigate patient morbidity from unnecessary health care interventions. Objectives: To identify and highlight important original investigations on medical overuse in dermatology from 2017 to 2018. Evidence Review: The PubMed and Embase databases coupled with articles published in 8 major dermatology and medical journals from January 1, 2017, to December 31, 2018, were searched to identify articles related to medical overuse in dermatology. Findings: Of 1941 candidate articles identified through the database search and 41 through the manual journal review, 38 were deemed relevant to medical overuse in dermatology by 2 independent reviewers. Twenty-eight of these articles were determined to be high priority based on scoring for quality of methods, magnitude of clinical effect, and number of patients potentially affected. After expert reviewer scoring, 10 articles were selected for analysis based on highest scores and greatest clinical significance. Selected articles covered topics such as dermatology consultation for cellulitis, management of dysplastic nevi, prognostic utility of sentinel lymph node biopsy, laboratory monitoring for terbinafine and isotretinoin, and safe medication prescribing. For cellulitis management, dermatology consultation is important for reducing misdiagnosis, unnecessary hospitalization, and inappropriate use of antibiotics. Findings related to common dermatologic procedures revealed that clinical observation is safe for dysplastic nevi and that sentinel lymph node biopsy may not have prognostic utility over Breslow thickness. In monitoring for terbinafine and isotretinoin, patient education on clinical symptoms is likely more effective than standard laboratory test result monitoring. Finally, dermatologists should reconsider the use of cyclosporine in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis and reevaluate the use of perioperative narcotics for patients. Conclusions and Relevance: This review notes actionable, evidence-based practices to reduce medical overuse in dermatology. This work may help to facilitate management changes to emphasize high-value care in dermatology while promoting awareness and further evaluation of overuse in medicine.

Original languageEnglish (US)
Pages (from-to)1410-1415
Number of pages6
JournalJAMA Dermatology
Volume155
Issue number12
DOIs
StatePublished - Dec 2019

Fingerprint

Dermatology
terbinafine
Dysplastic Nevus Syndrome
Sentinel Lymph Node Biopsy
Isotretinoin
Cellulitis
Referral and Consultation
Databases
Stevens-Johnson Syndrome
Medical Overuse
Evidence-Based Practice
Narcotics
Patient Education
Diagnostic Errors
PubMed
Cyclosporine
Hospitalization
Research Design
Observation
Medicine

ASJC Scopus subject areas

  • Dermatology

Cite this

A State-of-the-Art Review Highlighting Medical Overuse in Dermatology, 2017-2018 : A Systematic Review. / Pournamdari, Ashley B.; Tkachenko, Elizabeth; Barbieri, John; Adamson, Adewole S.; Mostaghimi, Arash.

In: JAMA Dermatology, Vol. 155, No. 12, 12.2019, p. 1410-1415.

Research output: Contribution to journalReview article

Pournamdari, Ashley B. ; Tkachenko, Elizabeth ; Barbieri, John ; Adamson, Adewole S. ; Mostaghimi, Arash. / A State-of-the-Art Review Highlighting Medical Overuse in Dermatology, 2017-2018 : A Systematic Review. In: JAMA Dermatology. 2019 ; Vol. 155, No. 12. pp. 1410-1415.
@article{fb0eb73706914d1398bdbe45f2435adb,
title = "A State-of-the-Art Review Highlighting Medical Overuse in Dermatology, 2017-2018: A Systematic Review",
abstract = "Importance: Emerging efforts to recognize and combat medical overuse are important solutions to mitigate patient morbidity from unnecessary health care interventions. Objectives: To identify and highlight important original investigations on medical overuse in dermatology from 2017 to 2018. Evidence Review: The PubMed and Embase databases coupled with articles published in 8 major dermatology and medical journals from January 1, 2017, to December 31, 2018, were searched to identify articles related to medical overuse in dermatology. Findings: Of 1941 candidate articles identified through the database search and 41 through the manual journal review, 38 were deemed relevant to medical overuse in dermatology by 2 independent reviewers. Twenty-eight of these articles were determined to be high priority based on scoring for quality of methods, magnitude of clinical effect, and number of patients potentially affected. After expert reviewer scoring, 10 articles were selected for analysis based on highest scores and greatest clinical significance. Selected articles covered topics such as dermatology consultation for cellulitis, management of dysplastic nevi, prognostic utility of sentinel lymph node biopsy, laboratory monitoring for terbinafine and isotretinoin, and safe medication prescribing. For cellulitis management, dermatology consultation is important for reducing misdiagnosis, unnecessary hospitalization, and inappropriate use of antibiotics. Findings related to common dermatologic procedures revealed that clinical observation is safe for dysplastic nevi and that sentinel lymph node biopsy may not have prognostic utility over Breslow thickness. In monitoring for terbinafine and isotretinoin, patient education on clinical symptoms is likely more effective than standard laboratory test result monitoring. Finally, dermatologists should reconsider the use of cyclosporine in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis and reevaluate the use of perioperative narcotics for patients. Conclusions and Relevance: This review notes actionable, evidence-based practices to reduce medical overuse in dermatology. This work may help to facilitate management changes to emphasize high-value care in dermatology while promoting awareness and further evaluation of overuse in medicine.",
author = "Pournamdari, {Ashley B.} and Elizabeth Tkachenko and John Barbieri and Adamson, {Adewole S.} and Arash Mostaghimi",
year = "2019",
month = "12",
doi = "10.1001/jamadermatol.2019.3064",
language = "English (US)",
volume = "155",
pages = "1410--1415",
journal = "JAMA Dermatology",
issn = "2168-6068",
publisher = "American Medical Association",
number = "12",

}

TY - JOUR

T1 - A State-of-the-Art Review Highlighting Medical Overuse in Dermatology, 2017-2018

T2 - A Systematic Review

AU - Pournamdari, Ashley B.

AU - Tkachenko, Elizabeth

AU - Barbieri, John

AU - Adamson, Adewole S.

AU - Mostaghimi, Arash

PY - 2019/12

Y1 - 2019/12

N2 - Importance: Emerging efforts to recognize and combat medical overuse are important solutions to mitigate patient morbidity from unnecessary health care interventions. Objectives: To identify and highlight important original investigations on medical overuse in dermatology from 2017 to 2018. Evidence Review: The PubMed and Embase databases coupled with articles published in 8 major dermatology and medical journals from January 1, 2017, to December 31, 2018, were searched to identify articles related to medical overuse in dermatology. Findings: Of 1941 candidate articles identified through the database search and 41 through the manual journal review, 38 were deemed relevant to medical overuse in dermatology by 2 independent reviewers. Twenty-eight of these articles were determined to be high priority based on scoring for quality of methods, magnitude of clinical effect, and number of patients potentially affected. After expert reviewer scoring, 10 articles were selected for analysis based on highest scores and greatest clinical significance. Selected articles covered topics such as dermatology consultation for cellulitis, management of dysplastic nevi, prognostic utility of sentinel lymph node biopsy, laboratory monitoring for terbinafine and isotretinoin, and safe medication prescribing. For cellulitis management, dermatology consultation is important for reducing misdiagnosis, unnecessary hospitalization, and inappropriate use of antibiotics. Findings related to common dermatologic procedures revealed that clinical observation is safe for dysplastic nevi and that sentinel lymph node biopsy may not have prognostic utility over Breslow thickness. In monitoring for terbinafine and isotretinoin, patient education on clinical symptoms is likely more effective than standard laboratory test result monitoring. Finally, dermatologists should reconsider the use of cyclosporine in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis and reevaluate the use of perioperative narcotics for patients. Conclusions and Relevance: This review notes actionable, evidence-based practices to reduce medical overuse in dermatology. This work may help to facilitate management changes to emphasize high-value care in dermatology while promoting awareness and further evaluation of overuse in medicine.

AB - Importance: Emerging efforts to recognize and combat medical overuse are important solutions to mitigate patient morbidity from unnecessary health care interventions. Objectives: To identify and highlight important original investigations on medical overuse in dermatology from 2017 to 2018. Evidence Review: The PubMed and Embase databases coupled with articles published in 8 major dermatology and medical journals from January 1, 2017, to December 31, 2018, were searched to identify articles related to medical overuse in dermatology. Findings: Of 1941 candidate articles identified through the database search and 41 through the manual journal review, 38 were deemed relevant to medical overuse in dermatology by 2 independent reviewers. Twenty-eight of these articles were determined to be high priority based on scoring for quality of methods, magnitude of clinical effect, and number of patients potentially affected. After expert reviewer scoring, 10 articles were selected for analysis based on highest scores and greatest clinical significance. Selected articles covered topics such as dermatology consultation for cellulitis, management of dysplastic nevi, prognostic utility of sentinel lymph node biopsy, laboratory monitoring for terbinafine and isotretinoin, and safe medication prescribing. For cellulitis management, dermatology consultation is important for reducing misdiagnosis, unnecessary hospitalization, and inappropriate use of antibiotics. Findings related to common dermatologic procedures revealed that clinical observation is safe for dysplastic nevi and that sentinel lymph node biopsy may not have prognostic utility over Breslow thickness. In monitoring for terbinafine and isotretinoin, patient education on clinical symptoms is likely more effective than standard laboratory test result monitoring. Finally, dermatologists should reconsider the use of cyclosporine in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis and reevaluate the use of perioperative narcotics for patients. Conclusions and Relevance: This review notes actionable, evidence-based practices to reduce medical overuse in dermatology. This work may help to facilitate management changes to emphasize high-value care in dermatology while promoting awareness and further evaluation of overuse in medicine.

UR - http://www.scopus.com/inward/record.url?scp=85074214177&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85074214177&partnerID=8YFLogxK

U2 - 10.1001/jamadermatol.2019.3064

DO - 10.1001/jamadermatol.2019.3064

M3 - Review article

C2 - 31642872

AN - SCOPUS:85074214177

VL - 155

SP - 1410

EP - 1415

JO - JAMA Dermatology

JF - JAMA Dermatology

SN - 2168-6068

IS - 12

ER -